Dabigatran is a direct inhibitor of thrombin and anticoagulant which is used for prevention of stroke and venous embolism in patients with chronic atrial fibrillation. Dabigatran was approved for medical use in 2010.
SynZeal offers all Dabigatran related impurities standards with certified COA and characterization data like IR, Mass, HPLC, purity, NMR & TGA report. We also provide CMR, DEPT and detailed structure characterization report as per requirements. Dabigatran related standards are being used by major pharmaceutical companies across the globe for their ANDA/DMF filing.
Dabigatran
Wednesday, September 8, 2021
Leave your comment